A detailed history of Main Line Retirement Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Main Line Retirement Advisors, LLC holds 828 shares of LLY stock, worth $619,352. This represents 0.5% of its overall portfolio holdings.

Number of Shares
828
Previous 832 0.48%
Holding current value
$619,352
Previous $753,000 2.66%
% of portfolio
0.5%
Previous 0.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

SELL
$772.14 - $960.02 $3,088 - $3,840
-4 Reduced 0.48%
828 $733,000
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $4,349 - $5,454
6 Added 0.73%
832 $753,000
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $1,050 - $1,238
2 Added 0.24%
826 $482 Million
Q2 2023

Aug 01, 2023

BUY
$350.74 - $468.98 $289,009 - $386,439
824 New
824 $386 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Main Line Retirement Advisors, LLC Portfolio

Follow Main Line Retirement Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Line Retirement Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Line Retirement Advisors, LLC with notifications on news.